376 related articles for article (PubMed ID: 35081892)
1. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
[TBL] [Abstract][Full Text] [Related]
2. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
3. Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs.
Kanwal U; Bukhari NI; Rana NF; Rehman M; Hussain K; Abbas N; Mehmood A; Raza A
Int J Nanomedicine; 2019; 14():1-15. PubMed ID: 30587981
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
6. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
7. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
8. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
[TBL] [Abstract][Full Text] [Related]
9. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
10. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
Haque ST; Islam RA; Gan SH; Chowdhury EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
[No Abstract] [Full Text] [Related]
11. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
[TBL] [Abstract][Full Text] [Related]
12. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X
Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
Arif M; Raja MA; Zeenat S; Chi Z; Liu C
J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer.
Wang Y; Qian J; Yang M; Xu W; Wang J; Hou G; Ji L; Suo A
Carbohydr Polym; 2019 Dec; 225():115206. PubMed ID: 31521263
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin.
Li M; Tang Z; Lv S; Song W; Hong H; Jing X; Zhang Y; Chen X
Biomaterials; 2014 Apr; 35(12):3851-64. PubMed ID: 24495487
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis of folate modified chitosan-based nanomicelles and its
Liu L; Huang G; Bai H; Tang G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):364-374. PubMed ID: 32762172
[TBL] [Abstract][Full Text] [Related]
20. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]